Mchayleh_Wassim_09_17__MID_550.pdf
9_17_2025_ECFONS_Program_Invite.pdf
You are cordially invited to attend an educational program on ORSERDU forpatients with ER+/HER2- ESR1- mutated mBC, upon progression on 1L ET + CDK4/6i presented by Dr. Wassim McHayleh and sponsored by Stemline Therapeutics, Inc., a Menarini Group Company.